UNC Pleural Fluid Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

9999 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-24

Study Completion Date

2050-01-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Research with biospecimens such as blood, tissue, or body fluids can help researchers understand how the human body works. Researchers can make new tests to find diseases, understand how treatments work, or find new ways to treat a disease. The purpose of this study is to collect biospecimens for research from patients with known or suspected lung cancer. The information learned from the biospecimens may be used in future treatments. The purpose of this protocol is to create a pleural fluid registry for use in future studies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors

NCT03189108

Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer +1 more

TERMINATED

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

NCT01137643

Chronic Myeloproliferative Disorders Leukemia Lymphoma +5 more

RECRUITING

Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer

NCT00899782

Lung Carcinoma Lung Neoplasm Malignant Lung Neoplasm

COMPLETED

Molecular Analysis of Thoracic Malignancies

NCT01385722

Thymus Cancer Thymoma Thymic Carcinoma +3 more

ENROLLING_BY_INVITATION

Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202

NCT01503619

Lung Cancer

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer Lung Infection Breast Cancer Malignant Pleural Effusion Empyema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pleural Fluid Registry

Any subject who has pleural fluid buildup from lung cancer, breast cancer, or lung infection

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are 18 years or older
* Inpatients and outpatients
* Diagnosed with pleural fluid, are referred for and undergo clinically indicated drainage who have clinical evidence of:
* pulmonary infection (such as fever, leukocytosis, new or worsening infiltrate on chest x-ray, or clinical deterioration) with effusion
* malignancy

Exclusion Criteria

* A subject will not be eligible for inclusion in this registry if, in the investigator's (or treating clinician's) opinion, the patient has any concurrent medical condition that may preclude their ability to undergo pleural fluid drainage safely.
* Incarcerated individuals

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No